Ralexar Therapeutics has a total of 51 patents globally, out of which 25 have been granted. Of these 51 patents, more than 33% patents are active. The USA is where Ralexar Therapeutics has filed the maximum number of patents. Parallelly, the United States seems to be the main focused R&D center of Ralexar Therapeutics and is also the origin country of the firm.
Ralexar Therapeutics was founded in the year 2013 by Raju Mohan. The company develops topical and systemic therapies designed to treat various dermatological conditions.
Do read about some of the most popular patents of Ralexar Therapeutics which have been covered by us in this article and also you can find Ralexar Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Ralexar Therapeutics patent portfolio.
How many patents does Ralexar Therapeutics have?
Ralexar Therapeutics has a total of 51 patents globally. These patents belong to 7 unique patent families. Out of 51 patents, 17 patents are active.
How Many Patents did Ralexar Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant
Ralexar Therapeutics Applications Filed
Ralexar Therapeutics Patents Granted
2022
–
–
2021
–
1
2020
1
3
2019
1
7
2018
6
8
2017
2
4
2016
–
–
2015
2
2
2014
13
–
2013
26
–
2012
–
–
2011
–
–
How many Ralexar Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Ralexar Therapeutics File in Different Countries?
Countries in which Ralexar Therapeutics Filed Patents
Country
Patents
United States Of America
7
Singapore
3
Korea (South)
3
Japan
3
Europe
3
Canada
2
China
2
New Zealand
2
Hong Kong (S.A.R.)
2
Australia
2
Brazil
2
Israel
2
Spain
1
Serbia
1
Poland
1
Hungary
1
Slovakia
1
Albania
1
Germany
1
Cyprus
1
Portugal
1
Denmark
1
Austria
1
Lithuania
1
Slovenia
1
Malta
1
Turkey
1
Estonia
1
Croatia
1
Norway
1
Where are Research Centres of Ralexar Therapeutics Patents Located?
Most Cited Ralexar Therapeutics Patents
US8987318B2 is the most popular patent in the Ralexar Therapeutics portfolio. It has received 6 citations so far.
What are Ralexar Therapeutics key innovation segments?
What Technologies are Covered by Ralexar Therapeutics?
The chart below distributes patents filed by Ralexar Therapeuticsin different countries on the basis of the technology protected in patents. It also represents the markets where Ralexar Therapeutics thinks it’s important to protect particular technology inventions.
R&D Focus: How has Ralexar Therapeutics search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Ralexar Therapeutics?
Qubitekk has a total of 36 patents globally, out of which 30 have been granted. Of these 36 patents, more than 55% patents are active. Japan and Austria are where…
Teva Pharmaceutical has a total of 12,798 patents globally, out of which 4,457 are granted. Out of these 12,798 patents, 26.40% are currently active. Teva has filed the maximum number…
IonQ has a total of 482 patents globally, out of which 254 have been granted. Of these 482 patents, 88% patents are active. The United States of America is where…
Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Countries in which Ralexar Therapeutics Filed Patents
